Cargando…

The role of prostate tumor overexpressed 1 in cancer progression

Detalles Bibliográficos
Autores principales:	Cánovas, Verónica, Lleonart, Matilde, Morote, Juan, Paciucci, Rosanna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355357/ https://www.ncbi.nlm.nih.gov/pubmed/28029646 http://dx.doi.org/10.18632/oncotarget.14104

Ejemplares similares

Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells
por: Cánovas, Verónica, et al.
Publicado: (2017)

Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression
por: Alaña, Lide, et al.
Publicado: (2014)

Cancer, Senescence, and Aging: Translation from Basic Research to Clinics
por: LLeonart, Matilde E., et al.
Publicado: (2011)

STAT3 inhibition with galiellalactone effectively targets the prostate cancer stem-like cell population
por: Canesin, Giacomo, et al.
Publicado: (2020)

Overexpression of prostate tumor overexpressed 1 correlates with tumor progression and predicts poor prognosis in breast cancer
por: Lei, Fangyong, et al.
Publicado: (2014)

Definition of Castrate Resistant Prostate Cancer: New Insights
por: Morote, Juan, et al.
Publicado: (2022)

DKC1 overexpression associated with prostate cancer progression
por: Sieron, P, et al.
Publicado: (2009)

Role of Serum Cholesterol and Statin Use in the Risk of Prostate Cancer Detection and Tumor Aggressiveness
por: Morote, Juan, et al.
Publicado: (2014)

Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer
por: Sequeiros, Tamara, et al.
Publicado: (2016)

Bypassing Mechanisms of Mitochondria-Mediated Cancer Stem Cells Resistance to Chemo- and Radiotherapy
por: Lyakhovich, Alex, et al.
Publicado: (2016)

Role of Calcium Signaling in Prostate Cancer Progression: Effects on Cancer Hallmarks and Bone Metastatic Mechanisms
por: Ardura, Juan A., et al.
Publicado: (2020)

Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies
por: Benavente, Sergi, et al.
Publicado: (2020)

Senescence induction; a possible cancer therapy
por: LLeonart, Matilde E, et al.
Publicado: (2009)

Role of Lipids and Lipid Metabolism in Prostate Cancer Progression and the Tumor’s Immune Environment
por: Siltari, Aino, et al.
Publicado: (2022)

miR-99a reveals two novel oncogenic proteins E2F2 and EMR2 and represses stemness in lung cancer
por: Feliciano, Andrea, et al.
Publicado: (2017)

Tumor Profiling at the Service of Cancer Therapy
por: Fernandez-Rozadilla, Ceres, et al.
Publicado: (2021)

Overexpression of BUB1B contributes to progression of prostate cancer and predicts poor outcome in patients with prostate cancer
por: Fu, Xin, et al.
Publicado: (2016)

Overexpression of TPX2 is associated with progression and prognosis of prostate cancer
por: Zou, Jun, et al.
Publicado: (2018)

SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations
por: Mateo, Francesca, et al.
Publicado: (2014)

APRIL is overexpressed in cancer: link with tumor progression
por: Moreaux, Jérôme, et al.
Publicado: (2009)

The role of hypoxia on prostate cancer progression and metastasis
por: Mohamed, Osama A. A., et al.
Publicado: (2023)

Overexpression of MUC1 and Genomic Alterations in Its Network Associate with Prostate Cancer Progression
por: Lin, Xiaozeng, et al.
Publicado: (2017)

The role of microRNAs in prostate cancer progression
por: Lo, U-Ging, et al.
Publicado: (2013)

Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer
por: Zhang, Yixiang, et al.
Publicado: (2017)

Prostate Tumor Overexpressed 1 Is a Novel Prognostic Marker for Hepatocellular Carcinoma Progression and Overall Patient Survival
por: Chen, Shu-Peng, et al.
Publicado: (2015)

Multidisciplinary Consensus on the Prevention and Treatment of Osteoporosis and Fragility Fractures in Patients with Prostate Cancer Receiving Androgen-Deprivation Therapy
por: Casado, Enrique, et al.
Publicado: (2022)

The Present and Future of Prostate Cancer Urine Biomarkers
por: Rigau, Marina, et al.
Publicado: (2013)

The Role of Sphingolipids Metabolism in Cancer Drug Resistance
por: Bataller, Marina, et al.
Publicado: (2021)

Cancer progression by breast tumors with Pit-1-overexpression is blocked by inhibition of metalloproteinase (MMP)-13
por: Sendon-Lago, Juan, et al.
Publicado: (2014)

Magnetic Resonance Imaging-Based Predictive Models for Clinically Significant Prostate Cancer: A Systematic Review
por: Triquell, Marina, et al.
Publicado: (2022)

Cell Plasticity and Prostate Cancer: The Role of Epithelial–Mesenchymal Transition in Tumor Progression, Invasion, Metastasis and Cancer Therapy Resistance
por: Papanikolaou, Sofia, et al.
Publicado: (2021)

Progress in the Identification of Dengue Virus Entry/Fusion Inhibitors
por: De La Guardia, Carolina, et al.
Publicado: (2014)

Molecular Markers for Prostate Cancer in Formalin-Fixed Paraffin-Embedded Tissues
por: Sequeiros, Tamara, et al.
Publicado: (2013)

Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes
por: Yang, Qi, et al.
Publicado: (2015)

The role of PPARγ in prostate cancer development and progression
por: Hartley, Andrew, et al.
Publicado: (2022)

The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer
por: Bishop, Jennifer L., et al.
Publicado: (2014)

Roles of Matrix Metalloproteinases and Their Natural Inhibitors in Prostate Cancer Progression
por: Gong, Yixuan, et al.
Publicado: (2014)

The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression
por: Lo, U-Ging, et al.
Publicado: (2017)

A Systematic Review of the Current Status of Magnetic Resonance–Ultrasound Images Fusion Software Platforms for Transperineal Prostate Biopsies
por: Paesano, Nahuel, et al.
Publicado: (2023)

Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression
por: Matos, Andreia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rkrd516jafs3u72gkbfsfpii8d